RETA Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-04-28 | 2020 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 421,100 | 339,500 | 0 | 0 | 0 | 3,965,242 |
| 2023-04-28 | 2021 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 421,100 | 142,121 | 0 | 0 | 0 | 1,817,137 |
| 2023-04-28 | 2022 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 514,000 | 259,056 | 956,200 | 0 | 0 | 2,859,636 |
| 2023-04-28 | 2020 | Colin J. Meyer, M.D. Chief Innovation Officer and Executive Vice President | 513,951 | 381,400 | 0 | 0 | 0 | 4,233,520 |
| 2023-04-28 | 2021 | Colin J. Meyer, M.D. Chief Innovation Officer and Executive Vice President | 540,000 | 202,500 | 0 | 0 | 0 | 2,566,378 |
| 2023-04-28 | 2022 | Colin J. Meyer, M.D. Chief Innovation Officer and Executive Vice President | 540,000 | 302,400 | 956,200 | 0 | 0 | 2,928,980 |
| 2023-04-28 | 2020 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 422,000 | 239,900 | 0 | 0 | 5,000 | 3,871,542 |
| 2023-04-28 | 2021 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 422,000 | 142,425 | 0 | 0 | 5,000 | 1,823,341 |
| 2023-04-28 | 2022 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 422,000 | 212,688 | 956,200 | 0 | 17,703 | 2,738,971 |
| 2023-04-28 | 2020 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and President | 545,900 | 445,700 | 0 | 0 | 136,125 | 4,465,894 |
| 2023-04-28 | 2021 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and President | 545,900 | 204,752 | 0 | 0 | 401,214 | 2,975,744 |
| 2023-04-28 | 2022 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and President | 545,900 | 305,704 | 1,366,000 | 0 | 170,174 | 4,002,607 |
| 2023-04-28 | 2020 | J. Warren Huff Chief Executive Officer and Chairman of the Board | 636,400 | 413,660 | 0 | 0 | 5,000 | 6,396,130 |
| 2023-04-28 | 2021 | J. Warren Huff Chief Executive Officer and Chairman of the Board | 636,400 | 0 | 0 | 0 | 6,000 | 4,031,773 |
| 2023-04-28 | 2022 | J. Warren Huff Chief Executive Officer and Chairman of the Board | 636,400 | 463,299 | 0 | 0 | 7,000 | 1,106,699 |
| 2022-04-29 | 2021 | J. Warren Huff Chief Executive Officer and Chairman of the Board | 636,400 | 0 | 0 | 0 | 6,000 | 4,031,773 |
| 2022-04-29 | 2020 | J. Warren Huff Chief Executive Officer and Chairman of the Board | 636,400 | 413,660 | 0 | 0 | 5,000 | 6,396,130 |
| 2022-04-29 | 2019 | J. Warren Huff Chief Executive Officer and Chairman of the Board | 578,500 | 600,540 | 0 | 0 | 16,715 | 5,542,605 |
| 2022-04-29 | 2021 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and President | 545,900 | 204,752 | 0 | 0 | 401,214 | 2,975,743 |
| 2022-04-29 | 2020 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and President | 545,900 | 445,700 | 0 | 0 | 136,125 | 4,465,894 |
| 2022-04-29 | 2019 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and President | 179,385 | 408,873 | 0 | 0 | 70,243 | 12,261,587 |
| 2022-04-29 | 2021 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 422,000 | 142,425 | 0 | 0 | 5,000 | 1,823,341 |
| 2022-04-29 | 2020 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 422,000 | 239,900 | 0 | 0 | 5,000 | 3,871,542 |
| 2022-04-29 | 2019 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 375,100 | 287,550 | 0 | 0 | 3,500 | 1,975,899 |
| 2022-04-29 | 2021 | Colin J. Meyer, M.D. Chief Innovation Officer and Executive Vice President | 540,000 | 202,500 | 0 | 0 | 0 | 2,566,378 |
| 2022-04-29 | 2020 | Colin J. Meyer, M.D. Chief Innovation Officer and Executive Vice President | 513,951 | 381,400 | 0 | 0 | 0 | 4,233,520 |
| 2022-04-29 | 2019 | Colin J. Meyer, M.D. Chief Innovation Officer and Executive Vice President | 445,600 | 389,467 | 0 | 0 | 0 | 2,182,780 |
| 2022-04-29 | 2021 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 421,100 | 142,121 | 0 | 0 | 0 | 1,817,137 |
| 2022-04-29 | 2020 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 421,100 | 339,500 | 0 | 0 | 0 | 3,965,242 |
| 2022-04-29 | 2019 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 382,800 | 341,400 | 0 | 0 | 0 | 2,033,949 |
| 2021-04-30 | 2019 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 375,100 | 287,550 | 0 | 0 | 3,500 | 1,975,899 |
| 2021-04-30 | 2020 | J. Warren Huff Chief Executive Officer, President and Chairman of the Board | 636,400 | 413,660 | 0 | 0 | 5,000 | 6,396,130 |
| 2021-04-30 | 2019 | J. Warren Huff Chief Executive Officer, President and Chairman of the Board | 578,500 | 600,540 | 0 | 0 | 16,715 | 5,542,605 |
| 2021-04-30 | 2020 | Colin J. Meyer, M.D. Chief Research and Development Officer and Executive Vice President | 513,951 | 381,400 | 0 | 0 | 0 | 4,233,520 |
| 2021-04-30 | 2019 | Colin J. Meyer, M.D. Chief Research and Development Officer and Executive Vice President | 445,600 | 389,467 | 0 | 0 | 0 | 2,182,780 |
| 2021-04-30 | 2018 | J. Warren Huff Chief Executive Officer, President and Chairman of the Board | 534,000 | 400,500 | 0 | 0 | 0 | 934,500 |
| 2021-04-30 | 2020 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 421,100 | 339,500 | 0 | 0 | 0 | 3,965,242 |
| 2021-04-30 | 2020 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and Executive Vice President | 545,900 | 445,700 | 0 | 0 | 136,125 | 4,465,894 |
| 2021-04-30 | 2019 | Manmeet S. Soni Chief Operation Officer, Chief Financial Officer and Executive Vice President | 179,385 | 408,873 | 0 | 0 | 70,243 | 12,261,587 |
| 2021-04-30 | 2020 | Dawn C. Bir Chief Commercial Officer and Executive Vice President | 422,000 | 239,900 | 0 | 0 | 5,000 | 3,871,542 |
| 2021-04-30 | 2019 | Michael D. Wortley Chief Legal Officer and Executive Vice President | 382,800 | 341,400 | 0 | 0 | 0 | 2,033,949 |
| 2021-04-30 | 2018 | Colin J. Meyer, M.D. Chief Research and Development Officer and Executive Vice President | 417,000 | 208,500 | 0 | 0 | 0 | 625,500 |
| 2020-04-29 | 2019 | Manmeet S. Soni | 530,000 | 408,873 | 0 | 0 | 70,243 | 12,612,202 |
| 2020-04-29 | 2019 | J. Warren Huff Chief Executive Officer, President and Chairman of the Board | 578,500 | 600,540 | 0 | 0 | 16,715 | 5,542,605 |
| 2020-04-29 | 2018 | J. Warren Huff Chief Executive Officer, President and Chairman of the Board | 534,000 | 400,500 | 0 | 0 | 0 | 934,500 |
| 2020-04-29 | 2017 | J. Warren Huff Chief Executive Officer, President and Chairman of the Board | 514,000 | 385,500 | 0 | 0 | 0 | 5,114,975 |
| 2020-04-29 | 2019 | Jason D. Wilson | 408,100 | 304,050 | 0 | 0 | 21,309 | 2,043,208 |
| 2020-04-29 | 2019 | Dawn C. Bir | 375,100 | 287,550 | 0 | 0 | 3,500 | 1,975,899 |
| 2020-04-29 | 2019 | Colin J. Meyer, M.D. Chief Medical Officer and Executive Vice President, Product Development | 445,600 | 389,467 | 0 | 0 | 0 | 2,182,780 |
| 2020-04-29 | 2018 | Colin J. Meyer, M.D. Chief Medical Officer and Executive Vice President, Product Development | 417,000 | 208,500 | 0 | 0 | 0 | 625,500 |
| 2020-04-29 | 2017 | Colin J. Meyer, M.D. Chief Medical Officer and Executive Vice President, Product Development | 400,000 | 200,000 | 0 | 0 | 0 | 2,083,537 |
| 2020-04-29 | 2019 | Michael D. Wortley | 382,800 | 341,400 | 0 | 0 | 0 | 2,033,949 |
| 2019-04-30 | 2018 | Chief Executive Officer | 534,000 | 400,500 | 0 | 0 | 0 | 934,500 |
| 2019-04-30 | 2018 | Chief Medical Officer | 417,000 | 208,500 | 0 | 0 | 0 | 625,500 |
| 2019-04-30 | 2018 | Chief Development Officer | 371,000 | 185,500 | 0 | 0 | 0 | 556,500 |
| 2018-04-30 | 2017 | J. Warren Huff Chief Executive Officer | 514,000 | 385,500 | 0 | 0 | 0 | 5,114,978 |
| 2018-04-30 | 2016 | Keith W. Ward, Ph.D. Chief Development Officer | 300,000 | 150,000 | 0 | 0 | 0 | 2,535,580 |
| 2018-04-30 | 2017 | Keith W. Ward, Ph.D. Chief Development Officer | 360,000 | 180,000 | 0 | 0 | 0 | 1,974,480 |
| 2018-04-30 | 2016 | Colin J. Meyer, M.D. Chief Medical Officer | 325,000 | 162,500 | 0 | 0 | 0 | 2,688,878 |
| 2018-04-30 | 2017 | Colin J. Meyer, M.D. Chief Medical Officer | 400,000 | 200,000 | 0 | 0 | 0 | 2,083,537 |
| 2018-04-30 | 2016 | J. Warren Huff Chief Executive Officer | 450,000 | 306,000 | 0 | 0 | 0 | 4,554,834 |
| 2017-04-24 | 2015 | Colin J. Meyer, M.D. Chief Medical Officer | 306,250 | 162,500 | 0 | 0 | 0 | 468,750 |
| 2017-04-24 | 2015 | J. Warren Huff Chief Executive Officer | 450,000 | 337,500 | 0 | 0 | 0 | 787,500 |
| 2017-04-24 | 2016 | J. Warren Huff Chief Executive Officer | 450,000 | 306,000 | 0 | 0 | 0 | 4,554,834 |
| 2017-04-24 | 2016 | Colin J. Meyer, M.D. Chief Medical Officer | 325,000 | 162,500 | 0 | 0 | 0 | 2,688,878 |
| 2017-04-24 | 2015 | Keith W. Ward, Ph.D. Chief Development Officer | 281,250 | 150,000 | 0 | 0 | 0 | 431,250 |
| 2017-04-24 | 2016 | Keith W. Ward, Ph.D. Chief Development Officer | 300,000 | 150,000 | 0 | 0 | 0 | 2,535,580 |
| 2016-08-15 | 2015 | J. Warren Huff Chief Executive Officer | 450,000 | 337,500 | 0 | 0 | 0 | 787,500 |
| 2016-08-15 | 2015 | Keith W. Ward, Ph.D. Chief Development Officer | 281,250 | 150,000 | 0 | 0 | 0 | 431,250 |
| 2016-08-15 | 2015 | Colin J. Meyer, M.D. Chief Medical Officer | 306,250 | 162,500 | 0 | 0 | 0 | 468,750 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
